Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from the Phase 3 ...

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, ...

Patients with type 2 diabetes mellitus (T2DM) have elevated risk for aortic stenosis (AS). The impact of diabetes on prognosis and clinical progression in AS is not well documented. In this study we ...

Researchers evaluated the association between GLP-1 receptor agonists and cardiovascular outcomes in adults with serious mental illness.

Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in ...

Artificial intelligence (AI) is increasingly being incorporated into cardiovascular imaging, but at Mass General Brigham, some of the most practical applications are focused on st ...

Doctoral dissertation research investigated how the family environment in childhood affects health in midlife.

Aspirin resistance is a major clinical concern that compromises the effectiveness of antiplatelet therapy in patients with Acute Coronary Syndrome (ACS). Genetic polymorphisms, particularly in TBXA2R ...

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and ...

A simple walking test flags which older survivors of myocardial infarction face the highest risk for cardiovascular outcomes.

The American Heart Association, American College of Cardiology and other U.S. medical societies have collaborated on new ...

A leading cardiovascular geneticist known for using human genetics and large population studies will be recognized by the American Heart Association at its annual Scientific Sessions in November.